Vera Spatenkova1, Ondrej Bradac2, Zdenek Jindrisek3, Jan Hradil4, Daniela Fackova5, Milada Halacova6. 1. Neurocenter, Neurointensive Care Unit, Regional Hospital, Husova 357/10, 46063, Liberec, Czech Republic. vera.spatenkova@nemlib.cz. 2. Department of Neurosurgery, Military University Hospital and First Medical School, Charles University, Prague, Czech Republic. 3. Neurocenter, Neurointensive Care Unit, Regional Hospital, Husova 357/10, 46063, Liberec, Czech Republic. 4. Neurocenter, Department of Neurosurgery, Regional Hospital, Liberec, Czech Republic. 5. Department of Clinical microbiology and immunology, Antibiotic Centre, Regional Hospital, Liberec, Czech Republic. 6. Department of Clinical Pharmacology, Na Homolce Hospital, Prague, Czech Republic.
Abstract
BACKGROUND: Surgical site infection (SSI) is a risk in every operation. Infections negatively impact patient morbidity and mortality and increase financial demands. The aim of this study was to analyse SSI and its risk factors in patients after thoracic or lumbar spine surgery. METHODS: A six-year single-centre prospective observational cohort study monitored the incidence of SSI in 274 patients who received planned thoracic or lumbar spinal surgery for degenerative disease, trauma, or tumour. They were monitored for up to 30 days postoperatively and again after 1 year. All patients received short antibiotic prophylaxis and stayed in the eight-bed neurointensive care unit (NICU) during the immediate postoperative period. Risk factors for SSI were sought using multivariate logistic regression analysis. RESULTS: We recorded 22 incidences of SSI (8.03%; superficial 5.84%, deep 1.82%, and organ 0.36%). Comparing patients with and without SSI, there were no differences in age (p=0.374), gender (p=0.545), body mass index (p=0.878), spine diagnosis (p=0.745), number of vertebrae (p=0.786), spine localization (p=0.808), implant use (p=0.428), American Society of Anesthesiologists (ASA) Score (p=0.752), urine catheterization (p=0.423), drainage (p=0.498), corticosteroid use (p=0.409), transfusion (p=0.262), ulcer prophylaxis (p=0.409) and diabetes mellitus (p=0.811). The SSI group had longer NICU stays (p=0.043) and more non-infectious hospital wound complications (p<0.001). SSI risk factors according to our multivariate logistic regression analysis were hospital wound complications (OR 20.40, 95% CI 7.32-56.85, p<0.001) and warm season (OR 2.92, 95% CI 1.03-8.27, p=0.044). CONCLUSIONS: Contrary to the prevailing literature, our study did not identify corticosteroids, diabetes mellitus, or transfusions as risk factors for the development of SSI. Only wound complications and warm seasons were significantly associated with SSI development according to our multivariate regression analysis.
BACKGROUND: Surgical site infection (SSI) is a risk in every operation. Infections negatively impact patient morbidity and mortality and increase financial demands. The aim of this study was to analyse SSI and its risk factors in patients after thoracic or lumbar spine surgery. METHODS: A six-year single-centre prospective observational cohort study monitored the incidence of SSI in 274 patients who received planned thoracic or lumbar spinal surgery for degenerative disease, trauma, or tumour. They were monitored for up to 30 days postoperatively and again after 1 year. All patients received short antibiotic prophylaxis and stayed in the eight-bed neurointensive care unit (NICU) during the immediate postoperative period. Risk factors for SSI were sought using multivariate logistic regression analysis. RESULTS: We recorded 22 incidences of SSI (8.03%; superficial 5.84%, deep 1.82%, and organ 0.36%). Comparing patients with and without SSI, there were no differences in age (p=0.374), gender (p=0.545), body mass index (p=0.878), spine diagnosis (p=0.745), number of vertebrae (p=0.786), spine localization (p=0.808), implant use (p=0.428), American Society of Anesthesiologists (ASA) Score (p=0.752), urine catheterization (p=0.423), drainage (p=0.498), corticosteroid use (p=0.409), transfusion (p=0.262), ulcer prophylaxis (p=0.409) and diabetes mellitus (p=0.811). The SSI group had longer NICU stays (p=0.043) and more non-infectious hospital wound complications (p<0.001). SSI risk factors according to our multivariate logistic regression analysis were hospital wound complications (OR 20.40, 95% CI 7.32-56.85, p<0.001) and warm season (OR 2.92, 95% CI 1.03-8.27, p=0.044). CONCLUSIONS: Contrary to the prevailing literature, our study did not identify corticosteroids, diabetes mellitus, or transfusions as risk factors for the development of SSI. Only wound complications and warm seasons were significantly associated with SSI development according to our multivariate regression analysis.
Authors: James N Weinstein; Tor D Tosteson; Jon D Lurie; Anna N A Tosteson; Brett Hanscom; Jonathan S Skinner; William A Abdu; Alan S Hilibrand; Scott D Boden; Richard A Deyo Journal: JAMA Date: 2006-11-22 Impact factor: 56.272
Authors: Justin S Smith; Christopher I Shaffrey; Charles A Sansur; Sigurd H Berven; Kai-Ming G Fu; Paul A Broadstone; Theodore J Choma; Michael J Goytan; Hilali H Noordeen; Dennis R Knapp; Robert A Hart; William F Donaldson; David W Polly; Joseph H Perra; Oheneba Boachie-Adjei Journal: Spine (Phila Pa 1976) Date: 2011-04-01 Impact factor: 3.468
Authors: Ambar Haleem; Hsiu-Yin Chiang; Ravindhar Vodela; Andrew Behan; Jean M Pottinger; Joseph Smucker; Jeremy D Greenlee; Charles Clark; Loreen A Herwaldt Journal: Infect Control Hosp Epidemiol Date: 2016-08-30 Impact factor: 3.254
Authors: Shearwood McClelland; Richelle C Takemoto; Baron S Lonner; Tate M Andres; Justin J Park; Pedro A Ricart-Hoffiz; John A Bendo; Jeffrey A Goldstein; Jeffrey M Spivak; Thomas J Errico Journal: Int J Spine Surg Date: 2016-04-21
Authors: Vera Spatenkova; Ondrej Bradac; Zuzana Mareckova; Petr Suchomel; Jan Hradil; Eduard Kuriscak; Milada Halacova Journal: Eur J Orthop Surg Traumatol Date: 2022-09-14